Using apolipoprotein B to manage dyslipidemic patients: time for a change?

@article{Harper2010UsingAB,
  title={Using apolipoprotein B to manage dyslipidemic patients: time for a change?},
  author={Charles Ryan Harper and Terry A Jacobson},
  journal={Mayo Clinic proceedings},
  year={2010},
  volume={85 5},
  pages={
          440-5
        }
}
Low-density lipoprotein cholesterol (LDL-C) concentration has been established as an independent risk factor for the development of atherosclerosis; consequently, multiple practice guidelines recognize LDL-C as the primary target of therapy.1,2 For decades, considerable effort has been committed to educating physicians and the general public about the importance of lowering LDL-C levels. Despite the extensive data relating LDL-C to atherosclerosis, some have suggested that focusing only on… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES